Menu Back to Event-Details

International Pharmacovigilance

Track:
DIAmond Sessions

Day & Time:
April 17, 2:00PM - 3:30PM (Central Europe Standard Time)

Session Number:
DMD5

Type:
Session

Title:
International Pharmacovigilance

Chair(s):
Esteban Herrero-Martinez, PhD
Director Regulatory Policy and Intelligence
Abbvie Ltd, United Kingdom

Description:
Pharmacovigilance is of increasing focus and importance internationally. Although welcome, huge variations in approach, legislative maturity, resource and fast-moving change are a challenge for all. We all have a responsibility to support development of effective pharmacovigilance systems globally to protect patients and support medicine delivery. With multiple activities worldwide and scarce resources, important key stakeholders must understand each other’s activities and support each other to achieve the same ultimate objectives.

Presentation(s) & Speaker(s):
Panel Discussion
Raj Long, MEd, MSc
Senior Regulatory Officer, Integrated Development, Global Health
Bill and Melinda Gates Foundation, United Kingdom

Panel Discussion
June Munro Raine, MD, MSc
Director - VRMM & Chairman of the PRAC
MHRA, United Kingdom

Panel Discussion
Amr Saad
Former Associate Minister of Health for Pharmaceutical Affairs
Founder, The Egyptian Pharmacovigilance Center (EPVC) , Egypt

Panel Discussion
Sue Rees, MS
EU QPPV, Executive Director, Global Patient Safety
Amgen Ltd, United Kingdom

Panel Discussion
Bahija Gouimi
Founder
AMAL, Morocco

Panel Discussion
Fergus Sweeney, PhD
Head of Inspections and Human Medicines Pharmacovigilance (Division)
European Medicines Agency, European Union, United Kingdom